The Dangers of Drug Price Controls and Their Impact on Healthcare

This chapter explores the consequences of implementing price controls on drug prices, with insights from a RAND study indicating potential declines in life expectancy and pharmaceutical innovation. It also examines the implications for U.S. healthcare policy amidst political shifts and skepticism toward European-style healthcare models.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app